Banca Ifis Logo

KOLINPHARMA, for innovative, inclusive and equitable science

A fair and inclusive society is also achieved by the work of companies that choose to embody these values through their workforce and in their products. One of the important goals set out in the UN 2030 Agenda is to attain gender equality and self-determination for all women, in education as well as employment.

KOLINPHARMA is an innovative SME, listed in the Euronext Growth Milan section of the Stock Exchange. The company specialises in the formulation, development and marketing of functional food supplements, particularly for uro-gynaecological and osteoarticular conditions.

The Company’s aim is to provide products which combine all the scientific rigour of pharmaceuticals with nutrition and food safety.

This attention also goes into the products. Indeed, they are specially formulated to address women’s issues, and the company’s investments in Research and Development also involve the area of gender medicine. But the design of their supplements also looks beyond gender issues. All their supplements are in fact certified as Kosher, Halal and Doping-free, to ensure they meet the needs of customers.

KOLINPHARMA has always been aware of issues related to women’s inclusion.

We are very attentive to the matter of equal opportunities. We have 104 employees, and 61% of them are women, working in a variety of strategic roles in the business. 64% of our Medical and Scientific Representatives are women.

Rita Paola Petrelli, Chairwoman of KOLINPHARMA's Board of Directors

“Achieving gender equality and self-determination for all women and girls” 

GOAL no. 5 of the 2030 Agenda for Sustainable Development